Clinical observation on every 3-week oxaliplatin plus 5-FU/CF regimen as postoperative adjuvant chemotherapy for colorectal cancer
10.3781/j.issn.1000-7431.2009.12.014
- VernacularTitle:奥沙利铂联合5-氟尿嘧啶/亚叶酸钙3周重复方案用于结直肠癌术后辅助化疗的临床观察
- Author:
Hao YU
;
Teng WANG
;
Dong HUA
- Publication Type:Journal Article
- Keywords:
Colorectal neoplasms;
Antineoplastic protocols;
Oxaliplatin
- From:
Tumor
2009;(12):1167-1169
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the clinical efficacy of every 3-week regimen of oxaliplatin (OXA) plus 5-fluorouracil (5-FU)/leucovorin(CF)as postoperative adjuvant chemotherapy for colorectal cancer.Methods:Ninety eight patients with stage Ⅱ to stage Ⅲ colorectal cancer received every 3-week OXA plus 5-FU/CF adjuvant chemotherapy for six cycles after resection surgery. All the patients received a complete reexamination every 3 months after the end of adjuvant chemotherapy. The disease-free survival period and 1- and 2-year disease-free survival rates were observed.Results:The total 2-year disease-free survival rate was 74.5%. It was 87.0% for stageⅡpatients and 63.5% for stage Ⅲ patients. The main adverse reaction included peripheral neurotoxicity, neutropenia and diarrhea at grades Ⅰ to Ⅱ. Grades Ⅲ to Ⅳ adverse reactions occurred rarely.Conclusion:The every 3-week OXA combined with 5-FU/CF adjuvant chemotherapy regimen had definite efficacy and good tolerance, which was a rational choice of postoperative adjuvant chemotherapy for colorectal cancer.
